Overview

Bupropion SR for Treating Smokeless Tobacco Use

Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
To determine the efficacy and safety of bupropion SR for quitting tobacco in smokeless tobacco users.
Phase:
Phase 3
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
West Virginia University
Treatments:
Bupropion
Lobeline